Premium
Anti‐diabetic Activity of Swertiamarin is due to an Active Metabolite, Gentianine, that Upregulates PPAR‐γ Gene Expression in 3T3‐L1 cells
Author(s) -
Vaidya Hitesh,
Goyal Ramesh K,
Cheema Sukhinder Kaur
Publication year - 2013
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.4763
Subject(s) - adiponectin , adipogenesis , metabolite , medicine , endocrinology , active metabolite , chemistry , peroxisome proliferator activated receptor , insulin resistance , diabetes mellitus , adipose tissue , receptor
We have previously shown the anti‐diabetic effects of swertiamarin; however, pharmacokinetic analysis showed that swertiamarin had a plasma half‐life of 1.3 h. Gentianine is an active metabolite of swertiamarin that possesses a pharmacophoric moiety. The aim of this study was to explore the possibility whether the anti‐diabetic effect of swertiamarin is due to gentianine. Swertiamarin treatment had no significant effect on adipogenesis, or the mRNA expression of PPAR‐γ and GLUT‐4; however, there was a significant increase in the mRNA expression of adiponectin. On the other hand, treatment with gentianine significantly increased adipogenesis, which was associated with a significant increase in the mRNA expression of PPAR‐γ, GLUT‐4 and adiponectin. These findings suggest, for the first time, that the anti‐diabetic effect of swertiamarin is due to gentianine, an active metabolite of swertiamarin. Copyright © 2012 John Wiley & Sons, Ltd.